No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US ETFDetailed Quotes
FBT First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund
- 165.530
- +1.510+0.92%
Close Dec 20 16:00 ET
166.780High162.150Low
166.780High162.150Low21.94KVolume163.790Open164.020Pre Close3.64MTurnover0.33%Turnover Ratio--P/E (Static)6.75MShares178.44652wk High--P/B1.12BFloat Cap139.40452wk Low1.17Dividend TTM6.75MShs Float185.240Historical High0.71%Div YieldTTM2.82%Amplitude32.564Historical Low165.828Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
Neurocrine Biosciences Analyst Ratings
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
(GILD) - Analyzing Gilead Sciences's Short Interest
Gilead Raises Assembly Bio Stake to ~30%
Wells Fargo Maintains Overweight on Argenx, Raises Price Target to $723